Methods for diagnosing, monitoring and controlling the onset and

Details Methods for diagnosing, monitoring and controlling the onset and Methods for diagnosing, monitoring and controlling the onset and

1989-03-13

1991-01-15

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Aluminum, calcium or magnesium element, or compound containing

424681, A61K 3306, A61K 3308, A61K 3310, A61K 3314

Patent

active

049852566

ABSTRACT:
Methods for diagnosing, monitoring and controlling the onset and progression of certain dementias, such as AD. The onset and progression of dementia are diagnosed and monitored by following changes in the relative concentrations of two forms of albumin in either serum of CSF. The onset and progression of dementia are controlled and memory loss is impeded or the impairment of memory is improved by dietary supplementation or the administration of Mg.

REFERENCES:
patent: 4788180 (1988-11-01), Block
Leszek, G. et al In: Magnesium Deficiency, Physiopathology and Treatment Implications, M. J. Halbert, J. Durlack (eds), First Eur. Congr. Magnesium, Lisbon, 1983, pp. 239-243 (Karger, Basel, 1985).
Chemistry of Foods & Nutrition, pp. 226, 562-565, The MacMillan Company, Sherman (1941).

Affiliated with

Also associated with

Rating

Methods for diagnosing, monitoring and controlling the onset and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for diagnosing, monitoring and controlling the onset and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagnosing, monitoring and controlling the onset and will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-54391